Tutorials
Arcellx Inc logo

Arcellx Inc

$ 19.54 -0.27 (-1.36%) 08:08 PM EST
P/E:
At Loss
P/B:
3.14
Market Cap:
$ 855.59M
Enterprise V:
$ 661.70M
Volume:
363.67K
Avg Vol (2M):
429.86K
Volume:
363.67K
Market Cap $:
855.59M
PE Ratio:
At Loss
Avg Vol (2-Month):
429.86K
Enterprise Value $:
661.70M
PB Ratio:
3.14
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Arcellx Inc
NAICS : 325412 SIC : 2834
25 West Watkins Mill Road, Suite A, Gaithersburg, MD, USA, 20878
Description
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 40.45
Equity-to-Asset 0.91
Debt-to-Equity 0.02
Debt-to-EBITDA -0.1
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 40.32
9-Day RSI 48.09
14-Day RSI 51.74
6-1 Month Momentum % 13.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.14
Quick Ratio 13.14
Cash Ratio 12.55

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

ACLX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ACLX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.867
Beta 0
Volatility % 0
14-Day RSI 51.74
14-Day ATR ($) 1.736909
20-Day SMA ($) 19.801
12-1 Month Momentum % 0
52-Week Range ($) 6.035 - 26.91
Shares Outstanding (Mil) 43.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arcellx Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More